News

News

New article in Nature Reviews Drug Discovery

Together with Rob Fisher from the Icahn School of Medicine at Mount Sinai, Matthias wrote a review article on the therapeutic potential of targeting transcriptional CDKs in cancer and inflammation.

A News & Views contribution in Nature

Matthias and Gregor wrote a News & Views piece in Nature on cryo-EM structures of cytoplasmic lattices, maternal storage systems that shelter proteins during early embryogenic development.

New paper in Nature Communications

Together with the team of Christa Müller from the Pharmaceutical Institute, Gregor uncovered a novel allosteric binding site in the P2X4 receptor, a promising drug target linked to chronic pain, inflammation, and cancer.

New paper in Blood

Together with Sneha Singh, Arijit Biswas and Johannes Oldenburg from the Institute of Hematology, Gregor and Matthias determined the first structure of the A and B subunits of Factor XIII. This tetrameric protein complex plays an important role in blood coagulation and is linked to many bleeding disorders.

New paper in Cell Chemical Biology

Congratulations to Jan Gerhartz, Dominika Pieńkowska, Ina Dressel and Thomas Geiger on a paper in Cell Chemical Biology. An engineered cereblon optimized for high throughput screening and molecular glue discovery - now in Cell Chemical Biology.

Review on Covalent PROTACs

Congratulations to Thomas Geiger on a new Book Chapter published in Annual Reports in Medicinal Chemistry. Proteolysis targeting chimeras (PROTACs) are hetero-bifunctional molecules that recruit E3 ubiquitin ligases, resulting in polyubiquitination and proteasomal degradation of disease-causing proteins.

New paper in Nature Communications

A serial switch for kinase activation: Double-phosphorylated Cdk7 turns on full activity! The Cyclin-dependent kinase 7 has two functions, it activates other CDKs to turn on the cell cycle and it phosphorylates RNA...

New paper in Cell Chemical Biology

Congratulations to Jan Gerhartz for his first publication of a PhD in the Nowak Lab! Jan wrote a perspective article summarizing a new concept of bifunctional small molecules that can dimerize proteins and therefore...

New paper in Nature Communications

A new way to inhibit pyroptosis! Anja characterized by biochemical means six nanobodies that were raised against human Gasdermin D.

New paper in JBC

SR-4835, a small molecule inhibitor currently in phase I clinical trials, targets transcriptional kinases Cdk12 and Cdk13. Biochemical and structural analyses could highlight SR-4835’s selectivity towards Cdk12/Cdk13...

Matthias receives an ERC Advanced Grant

We are very pleased to announce that Matthias has been awarded an ERC Advanced Grant for his proposal on the NLRP3 inflammasome. The EU will fund the work programme "Exploring inflammasome activation and targeted...

New review on the inflammasome

Inga and Matthias wrote a review article on the “Structural aspects of inflammasome-forming NOD-like receptors” for the book Fundamentals of Inflammasome Biology, edited by Pablo Pelegrín. In this review, they...

New paper in Nature

Our study on the type III CRISPR associated CalpL-T-S cascade has just been published in Nature. It’s an amazing story that started out of pure curiosity, when Christophe and Gregor decided to look into the structure...

New paper in Communications Biology

The binding and hydrolysis of ATP in NLRP3 remains a conundrum: The protein requires ATP for activation, but is not simply activated by excess of nucleotide. How nucleotide exchange is regulated is unclear, as is the...

New paper in JBC

Up to 50% of the population carry a single nucleotide polymorphism (SNP) in the gene encoding the inflammasome sensor Nlrp1. This SNP causes an amino acid exchange from methionine 1184 to valine (M1184V), and has...

New paper in Science Advances

First steps towards structural insights into the active NLRP3 inflammasome have been taken: We have determined the directionality of ASC PYD filament growth on NLRP3 PYD nucleation seeds! In a tedious titration...

New paper in Nature

The long-awaited structure of full-length, human NLRP3 is here! Inga and colleagues have done a great job determining the cryo-EM structure of this inflammasomal protein in the inactive state bound to the inhibitor...

New paper in Open Biology

Robert – who is now in the Fisher lab at MSSM, New York – published a great paper on Cdk10/Cyclin Q in Open Biology. Cyclin-dependent kinases (CDKs) perform multiple tasks in cells, e.g., coordination of cell...

New paper in Nature Communications

Abemaciclib is a third generation CDK-directed drug used in the treatment of HR + /HER2 negative advanced or metastatic breast cancer. In a new study by Ines and co-workers, we demonstrate that members of the...